Pacira Pharmaceuticals buy StockNews.com
Start price
05.08.23
/
50%
€35.80
Target price
05.08.24
-
Performance (%)
-46.93%
End price
06.08.24
€19.00
Summary
This prediction ended on 06.08.24 with a price of €19.00. Massive losses of -46.93% were the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Pacira Pharmaceuticals where he still thinks Pacira Pharmaceuticals is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 4.124% | 4.124% | 31.169% |
| iShares Core DAX® | 2.705% | -1.771% | 22.133% |
| iShares Nasdaq 100 | 4.127% | -1.874% | 11.324% |
| iShares Nikkei 225® | 1.944% | -3.187% | 15.692% |
| iShares S&P 500 | 2.919% | -0.149% | 4.642% |
Comments by StockNews_com for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten